Cite
Lebouché B, Yero A, Shi T, et al. Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy. HIV Res Clin Pract. 2021;21(6):182-190doi: 10.1080/25787489.2020.1866846.
Lebouché, B., Yero, A., Shi, T., Farnos, O., Singer, J., Kema, I., Costiniuk, C. T., Thomas, R., Brouillette, M. J., Engler, K., Routy, J. P., Jenabian, M. A. (2020). Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy. HIV research & clinical practice, 21(6), 182-190. https://doi.org/10.1080/25787489.2020.1866846
Lebouché, Bertrand, et al. "Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy." HIV research & clinical practice vol. 21,6 (2020): 182-190. doi: https://doi.org/10.1080/25787489.2020.1866846
Lebouché B, Yero A, Shi T, Farnos O, Singer J, Kema I, Costiniuk CT, Thomas R, Brouillette MJ, Engler K, Routy JP, Jenabian MA. Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy. HIV Res Clin Pract. 2020 Dec;21(6):182-190. doi: 10.1080/25787489.2020.1866846. Epub 2021 Jan 06. PMID: 33403940.
Copy
Download .nbib